We are live on ! Find out more
BLCM

Bellicum Pharmaceuticals, Inc.
BLCM

Delisted

BLCM was delisted on the 1st of June, 2023.

Back to rankings

27 hedge funds and large institutions have $7.68M invested in Bellicum Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

53,429% more call options, than puts

Call options by funds: $3.75M | Put options by funds: $7K

8% more capital invested

Capital invested by funds: $7.09M → $7.68M (+$589K)

7% less funds holding

Funds holding: 29 → 27 (-2)

17% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 6

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

Holders
27
Holders Change
-2
Holders Change %
-6.9%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
6
Closed
8
Calls
$3.75M
Puts
$7K
Net Calls
+$3.74M
Net Calls Change
+$1.44M

Top Buyers

Rank Fund Capital Flow
1
Principal Financial Group
Principal Financial Group
Iowa
+$362K
2
BCM
Bridgeway Capital Management
Texas
+$199K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$24.5K
4
BlackRock
BlackRock
New York
+$20.2K
5
UBS Group
UBS Group
Switzerland
+$14.3K

Top Sellers

Rank Fund Capital Flow
1
NAMA
Nikko Asset Management Americas
New York
-$1.02M
2
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
-$1.02M
3
Renaissance Technologies
Renaissance Technologies
New York
-$267K
4
Morgan Stanley
Morgan Stanley
New York
-$162K
5
SM
Sabby Management
Florida
-$89K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
26
Sabby Management
Florida
– -$89K -18,927 Closed
Millennium Management
27
Millennium Management
New York
– -$77K -16,521 Closed
Victory Capital Management
28
Victory Capital Management
Texas
– -$8K -1,626 Closed
Bank Julius Baer & Co
29
Bank Julius Baer & Co
Switzerland
– -$1K -214 Closed
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
– -$1K -200 Closed
CAPTRUST Financial Advisors
31
CAPTRUST Financial Advisors
North Carolina
– +$381 +56 New
PA
32
Parallel Advisors
California
– +$408 +60 New
1
2

BLCM Hedge Fund Activity: Q2 2020 in Review

27 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Bellicum Pharmaceuticals, Inc. (BLCM) for Q2 2020, worth a combined $7.68M — up 8.3% from $7.09M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of BLCM and 6 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 5 added.

The largest buyer was Principal Financial Group, opening a new position worth an estimated $362K. The largest seller was Nikko Asset Management Americas, exiting entirely with an estimated $1.02M sold.

  • 27 institutional investors held Bellicum Pharmaceuticals, Inc. (BLCM) as of Q2 2020, down from 29 in Q1 2020.
  • Funds reported $7.68M of Bellicum Pharmaceuticals, Inc. stock for Q2 2020, up 8.3% quarter-over-quarter.
  • 6 funds opened new Bellicum Pharmaceuticals, Inc. positions in Q2 2020 and 8 closed out, a net change of -2 holders.
  • The largest Bellicum Pharmaceuticals, Inc. buyer in Q2 2020 was Principal Financial Group, an estimated $362K added.
  • The largest Bellicum Pharmaceuticals, Inc. seller in Q2 2020 was Nikko Asset Management Americas, an estimated $1.02M sold.

Based on aggregated 13F filings for Q2 2020.